|
|
|
|
|
|
Life Technologies specializes in the development and marketing of instruments, reagents, and software used primarily in the fields of basic, pharmaceutical, and food-processing research, molecular diagnostics, and legal medicine.
Net sales break down by source of income into sales of products and services (97.1%) and other (2.9%; primarily royalties).
Net sales (not including royalties) break down geographically as follows: the United States (37.4%), Americas (6.2%), Europe (30%), Asia-Pacific (24.4%) and other (2%).
|
|
| Surperformance© rating of Life Technologies Corp. | |
|
|
Overall rating |
In sector |
In country |
| Trading Rating |
|
|
|
| Investor Rating |
|
|
|
| Growth (Revenue) |
|
|
|
| Valuation |
|
|
|
| Finances |
|
|
|
| Profitability |
|
|
|
| Earnings quality |
|
|
|
| Business Predictability |
|
|
|
| PER |
|
|
|
| Potential |
|
|
|
| Yield |
- |
- |
- |
| Consensus |
|
|
|
| 7 days EPS revision |
|
|
|
| 4 months EPS revision |
|
|
|
| 1 year EPS revision |
|
|
|
| 4 months Revenue revision |
|
|
|
| 1 year Revenue revision |
|
|
|
| |
|
|
|
|
Data source :
© 2013 Thomson Reuters |
|
Ratings :
© 2013 Surperformance |
|
|
|
|
|
| - Glenview Capital Management |
7,73% |
| - Primecap Management Company |
7,46% |
| - BlackRock |
6,74% |
| - The Vanguard Group |
5,42% |
| - Managers and Directors |
2,36% |
|
|
|
|
- Communications :
Carol Cox Wait |
- Chairman and Chief Executive Officer :
Gregory T. Lucier |
- Chief Financial Officer :
David F. Hoffmeister |
- Investor Relations :
Eileen Pattinson |
- General Secretary :
John A. Cottingham |
|
|
| Company contact information |
|
5791 way Van Allen
PO Box 6482
CA 92008 Carlsbad
USA
Phone : +1 760 603 7200
Fax : +1 760 602 6500
Internet : http://www.lifetech.com
|
|
|
|
- NASDAQ All Markets - Nasdaq Global Select Market - Nasdaq 100 / SP500 |
|
|
|
|
| - ISIN Code : |
US53217V1098 |
| - Bloomberg Code : |
LIFE:US |
| - Reuters Code : |
LIFE.O |
| - Datastream Code : |
|
|
Financial data source :
© 2013 Cofisem |
|
|
